Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HANK Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of haNK in colorectal cancer (CRC), sponsored by Fuda Cancer Hospital. Started Dec 2016; status: completed.
02
Drugs
haNK
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03008499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008499.